I thought that the earnings con call today was very upbeat and certainly another great quarter.. Clearly the CEO sees the share price as not yet re rated. Dividend strategy to be discussed by board and announced at end of fiscal year, Very much a growing cash machine for a long time and in safe hands
- Forums
- ASX - By Stock
- SBM
- Ann: Quarterly Report Q3 March 2017
Ann: Quarterly Report Q3 March 2017, page-5
Featured News
Add SBM (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $233.2M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.3¢ | $1.551M | 4.447M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 124478 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 272870 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32500 | 3.430 |
9 | 72187 | 3.420 |
11 | 203897 | 3.410 |
9 | 117260 | 3.400 |
11 | 118353 | 3.390 |
Price($) | Vol. | No. |
---|---|---|
3.440 | 192470 | 22 |
3.450 | 143302 | 12 |
3.460 | 61139 | 4 |
3.470 | 41621 | 7 |
3.480 | 81907 | 5 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
SBM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online